Apr 22, 2025
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.41 to $0.02.
The split itself did not change the total investment value.
Seres Therapeutics, Inc. (MCRB) trades on the NASDAQ Global Select in the Biotechnology industry.
Seres Therapeutics, Inc. company overviewThe latest split shown was on April 22, 2025. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on April 22, 2025.